This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Extrahepatic bile ducts (controls excluding all cancers)
CD2_BENIGN_EXTRAHEPATIC_BILE_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
D13.5&
Hospital discharge: ICD-8
2115[1-2]
Cause of death: ICD-10
D13.5&
Cause of death: ICD-8
2115[1-2]
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
61
CD2_BENIGN_EXTRAHEPATIC_BILE_EXALLC
Control definitions
Control exclude
C3_CANCER
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D13
Name in latin
Neoplasma benignum ductuum biliarium extrahepaticorum
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Extrahepatic bile ducts (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Benign neoplasm: Extrahepatic bile ducts
- Benign neoplasm: Liver/bile ducts (controls excluding all cancers)
- Benign neoplasm: Liver/bile ducts
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 61 | 36 | 25 |
| Unadjusted prevalence (%) | 0.02 | 0.02 | 0.02 |
| Mean age at first event (years) | 58.44 | 53.62 | 65.37 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_EXTRAHEPATIC_BILE_EXALLC – Benign neoplasm: Extrahepatic bile ducts (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign neoplasm: Extrahepatic bile ducts (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.